84 filings
Page 3 of 5
EFFECT
hz93gg9
11 Oct 22
Notice of effectiveness
12:15am
CORRESP
4lq77w6ucv
5 Oct 22
Correspondence with SEC
12:00am
UPLOAD
zzw7w hin
4 Oct 22
Letter from SEC
12:00am
S-3
ant2huxh
3 Oct 22
Shelf registration
8:31am
8-K
tn9 v72b36ny4
11 Aug 22
DICE Therapeutics Reports Second Quarter 2022 Financial Results and Recent Highlights
4:12pm
8-K
6udofl3i
28 Jun 22
Entry into a Material Definitive Agreement
4:01pm
8-K
ucbldiozoh8
8 Jun 22
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
j0tdad
12 May 22
DICE Therapeutics Reports First Quarter 2022 Financial Results and Recent Highlights
4:14pm
8-K
caea0
3 May 22
Regulation FD Disclosure
8:01am
DEFA14A
41f2 eg3kyc
26 Apr 22
Additional proxy soliciting materials
4:19pm
DEF 14A
7rc3 om2ee
26 Apr 22
Definitive proxy
4:15pm
S-8
rdoaly
28 Mar 22
Registration of securities for employees
4:50pm
8-K
9r9jdqv9i54dbsy2pvq
28 Mar 22
Departure of Directors or Certain Officers
4:15pm
10-K
iouak51
28 Mar 22
Annual report
4:06pm
8-K
54pt6g3y
21 Mar 22
DICE Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights
4:05pm
8-K
vb3tvfqg8gzxszi n1
17 Feb 22
Regulation FD Disclosure
6:06am
10-Q
98s70de0nzwd0 e38r
12 Nov 21
Quarterly report
8:15am
8-K
nqnwz agatjzdn
12 Nov 21
DICE Therapeutics Reports Third Quarter 2021 Financial Results and Recent Highlights
8:05am